Page 3 - James Bernstein News Today

On the rainy bank of the Pilchuck River in Snohomish, a growing St. Thomas Orthodox Church celebrated the Holy Trinity and the baptism of Jesus.

Companies may be picking up more of the expense while also emphasizing cheaper remote care. Some are offering perks like “lifestyle” stipends.

Sam Whiting April 15, 2021Updated: April 15, 2021, 4:28 pm Ed Green in 2010 Photo: Johnny Grace 2010 As a master picture framer, Ed Green’s goal was to select a raw piece of wood and create a quadrangle that no viewer would notice. “I don’t think what I do is art,” Green once said in a video on his website. “I consider it high craft in the support of art.” But his clients and colleagues, ranging from major art collectors to gallery owners and conservators, considered wh...

The Choice of Eating Cicadas or Supporting Local Farms: I swear I read an article, not even tongue-in-cheek on ZeroHedge (perhaps outside the search range I use or they pulled it; yes, in history, it is now “404” meaning dead) discussing the merits of eating the bugs. In any event, other sites discussed the topic of “Brood X” as a food source, very much a dream of the oligagarchs at the World Economic Forum. If you don’t have to own anything to be happy, you’ll be very happy eating ...

“The process is so convoluted, you need to streamline it,” said Bernstein. “She lives by herself, she has no TV, she has no internet. Limited phone access,” said Aida Nunez of Manchester, who struggled all day to help her 85-year-old friend from Hartford sign up. She said her friend has no family to help her. And even someone as tech savvy as her can’t figure it out. “All of these numbers say busy, busy, busy or you go to this website and how can I go to this website and if I don’...

by Barry Teater, NCBiotech writer — January 6, 2021 . RESEARCH TRIANGLE PARK – Raleigh-based Marius Pharmaceuticals, led by several former GlaxoSmithKline scientists and executives, is making progress on its first potential drug. Marius has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of Kyzatrex, its novel treatment for hypogonadism, or testosterone deficiency, in men. “Submission of our first NDA is an important milestone, bring...